The Invisible Disease: Depression

IntroductionDepression is a serious medical condition.and monoamine oxidase inhibitors (MAOIs). Although
In contrast to the normal emotional experiences ofboth generations of medications are effective in
sadness, loss, or passing mood states, clinicalrelieving depression, some people will respond to one
depression is persistent and can interfere significantlytype of drug, but not another. Other types of
with an individual's ability to function. There are threeantidepressants are now in development.Certain
main types of depressive disorders: major depressivetypes of psychotherapy, specifically
disorder, dysthymic disorder, and bipolar disordercognitive-behavioral therapy (CBT) and interpersonal
(manic-depressive illness).Symptoms and Types oftherapy (IPT), have been found helpful for
DepressionSymptoms of depression include saddepression. Research indicates that mild to moderate
mood, loss of interest or pleasure in activities thatdepression often can be treated successfully with
were once enjoyed, change in appetite or weight,either therapy alone; however, severe depression
difficulty sleeping or oversleeping, physical slowing orappears more likely to respond to a combination of
agitation, energy loss, feelings of worthlessness orpsychotherapy and medication. 7 More than 80
inappropriate guilt, difficulty thinking or concentrating,percent of people with depressive disorders improve
and recurrent thoughts of death or suicide. Awhen they receive appropriate treatment.In situations
diagnosis of major depressive disorder is made if awhere medication, psychotherapy, and the
person has 5 or more of these symptoms andcombination of these interventions prove ineffective,
impairment in usual functioning nearly every dayor work too slowly to relieve severe symptoms such
during the same two-week period. Major depressionas psychosis (e.g., hallucinations, delusional thinking) or
often begins between ages 15 to 30 but also cansuicidality, electroconvulsive therapy (ECT) may be
appear in children. 1 Episodes typically recur.Someconsidered. ECT is a highly effective treatment for
people have a chronic but less severe form ofsevere depressive episodes.The possibility of
depression, called dysthymic disorder, which islong-lasting memory problems, although a concern in
diagnosed when depressed mood persists for atthe past, has been significantly reduced with modern
least 2 years (1 year in children) and is accompaniedECT techniques. However, the potential benefits and
by at least 2 other symptoms of depression. Manyrisks of ECT, and of available alternative
people with dysthymia develop major depressiveinterventions, should be carefully reviewed and
episodes.Episodes of depression also occur in peoplediscussed with individuals considering this treatment
with bipolar disorder. In this disorder, depressionand, where appropriate, with family or friends.One
alternates with mania, which is characterized byherbal supplement, hypericum or St. John's wort, has
abnormally and persistently elevated mood orbeen promoted as having antidepressant properties.
irritability and symptoms including overly-inflatedResults from the first large-scale, controlled study of
self-esteem, decreased need for sleep, increasedSt. John's wort for major depression, which was
talkativeness, racing thoughts, distractibility, physicalfunded in part by NIMH, are expected in 2001. Note:
agitation, and excessive risk taking. Because bipolarThere is evidence that St. John's wort can reduce
disorder requires different treatment than majorthe effectiveness of certain medications. Use of any
depressive disorder or dysthymia, obtaining anherbal or natural supplements should always be
accurate diagnosis is extremely important.Factsdiscussed with your doctor before they are
About DepressionMajor depression is the leadingtried.Research FindingsBrain imaging research is
cause of disability in the U.S. and worldwide. 2revealing that in depression, neural circuits responsible
Depressive disorders affect an estimated 9.5 percentfor moods, thinking, sleep, appetite, and behavior fail
of adult Americans ages 18 and over in a given year,to function properly, and that the regulation of critical
3 or about 18.8 million people in 1998. Nearly twice asneurotransmitters is impaired. Genetics research,
many women (12 percent) as men (7 percent) areincluding studies of twins, indicates that genes play a
affected by a depressive disorder eachrole in depression. Vulnerability to depression appears
year.Depression can be devastating to familyto result from the influence of multiple genes acting
relationships, friendships, and the ability to work or gotogether with environmental factors.Other research
to school. Many people still believe that the emotionalhas shown that stressful life events, particularly in the
symptoms caused by depression are "not real," andform of loss such as the death of a close family
that a person should be able to shake off themember, may trigger major depression in susceptible
symptoms. Because of these inaccurate beliefs,individuals. The hypothalamic-pituitary-adrenal (HPA)
people with depression either may not recognize thataxis, the hormonal system that regulates the body's
they have a treatable disorder or may beresponse to stress, is overactive in many people with
discouraged from seeking or staying on treatmentdepression. Research findings suggest that persistent
due to feelings of shame and stigma. Too often,overactivation of this system may lay the
untreated or inadequately treated depression isgroundwork for depression.Studies of brain chemistry,
associated with suicide.TreatmentsAntidepressantmechanisms of action of antidepressant medications,
medications are widely used, effective treatmentsand the cognitive distortions and disturbed
for depression. Existing antidepressants influence theinterpersonal relationships commonly associated with
functioning of certain chemicals in the brain calleddepression, continue to inform the development of
neurotransmitters. The newer medications, such asnew and better treatments.New Clinical TrialsNIMH is
the selective serotonin reuptake inhibitors (SSRIs),funding two new, large-scale, multi-site clinical trials on
tend to have fewer side effects than the oldertreatments for major depression in adults and
drugs, which include tricyclic antidepressants (TCAs)adolescents.